Ironwood Pharmaceuticals IRWD Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Ironwood Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's interest coverage?
- Ironwood Pharmaceuticals (IRWD) reported interest coverage of 5.9× in Q1 2026.
- How has Ironwood Pharmaceuticals's interest coverage changed year-over-year?
- Ironwood Pharmaceuticals's interest coverage increased by 278.4% year-over-year, from 1.6× to 5.9×.
- What is the long-term trend for Ironwood Pharmaceuticals's interest coverage?
- Over 5 years (2020 to 2025), Ironwood Pharmaceuticals's interest coverage has grown at a -9.1% compound annual growth rate (CAGR), from 4.8× to 3×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.